CARRY RISK. WEIGHT WATCHERS SAYS IT WILL NOW OFFER ELIGIBLE MEMBERS COMPOUNDED SEMAGLUTIDE AS PART OF ITS HOLISTIC ...
Will the brand really follow through on their cancellations? And could compounded semaglutide be the once-housewife-favourite ...
Sima Sistani helped push the company into the GLP-1 drug space with the $106 million acquisition of Sequence.
Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.
As a binge eater, Charlotte Cripps thought the slimming wonder drug would offer a miracle cure for her cravings. She found out the hard way that wasn’t to ...
Under Sistani, the 61-year-old company bought a telehealth platform that connected patients with doctors who can prescribe weight-loss and diabetes drugs, including Ozempic and Wegovy ...